Catis Decision
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
26 Ch Lomer, Quebec, Quebec, G3A 1W7, Ca...Website
www.catalisquebec.comRevenue
$14.1 MillionIndustry
About Catis Decision
CATALIS Quebec is a non-profit partnership dedicated to the advancement and operational excellence of clinical research in Quebec. Launched in 2017, CATALIS aims to increase the number of conducted by companies in Quebec, facilitate collaboration between stakeholders, and accelerate the development of innovative treatments through governmental support and partnerships with public and private entities. The initiative combines brilliant physician-scientists, cutting-edge infrastructure, incentives, and AI technology to create a smart ecosystem for clinical trials, attracting major pharmaceutical companies to conduct research in Quebec.Explore more
Catis Decision Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Catis Decision
Compare insights from companies similar to Catis Decision, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Catis Decision Tech Stack
A closer look at the technologies used by Catis Decision
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Catis Decision
Sign Up For FreeTo access detailed company insights
CATALIS Quebec is a non-profit partnership dedicated to the advancement and operational excellence of clinical research in Quebec. Launched in 2017, CATALIS aims to increase the number of conducted by companies in Quebec, facilitate collaboration between stakeholders, and accelerate the development of innovative treatments through governmental supp... Read More
